While B-type natriuretic peptide (BNP) levels remain high in patients with end-stage heart failure with cardiogenic shock, these levels lose their prognostic value in patients using ventricular assist ...

Research published in the April 2011 issue of Anesthesiology examines whether the hormone plasma B-type natriuretic peptide helps indicate which patients are at risk of adverse cardiac events after ...

Brain natriuretic peptide (BNP), a substance secreted by the heart that is associated with congestive heart failure and renal failure, does not predict reduction in systolic blood pressure (BP) in ...

BNP levels in the blood reflects the severity of cardiac dysfunction. Higher BNP levels have been associated with adverse clinical outcomes. This study looked at end-stage heart failure patients with ...

Dr. Pankaj Arora, MD, FAHA, is a physician scientist in the Division of Cardiovascular Disease with expertise in the human genetics and genomics of complex cardiovascular traits, as well as ...

Diastolic heart failure is common in the elderly, particularly women. Previous studies on the value of brain natriuretic peptide in diastolic dysfunction have been largely limited to male subjects.

B-type natriuretic peptide (BNP) as well as its N-terminal fragment (NT-proBNP) can provide useful diagnostic and prognostic information in patients with acute dyspnea and chronic heart failure.

Luís Beck-da-Silva, MD; Adolfo de Bold, PhD, FRSC; Ross A. Davies, MD, FRCPC; Benjamin J.W. Chow, MD, FRCPC; Terrence D. Ruddy, MD, FRCPC; Margaret Fraser, RN ...